[16]
The plaintiffs allege that the defendant filed an application to register
Pneumocort
on February 26, 1993, as a pharmaceutical trademark for drugs used in the treatment of inflammation and asthma, marketing those preparations in Canada, and as a result
Pneumocort
was registered in the name of the defendant on May 27, 1994, the particulars of which are set out in Schedule "B" to the statement of claim.